These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15624031)

  • 1. HCV carriers with persistently normal ALT Levels: not too much healthy, not true patients.
    Puoti C
    Rom J Gastroenterol; 2004 Dec; 13(4):329-32. PubMed ID: 15624031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Shiffman ML; Diago M; Tran A; Pockros P; Reindollar R; Prati D; Rodríguez-Torres M; Lardelli P; Blotner S; Zeuzem S
    Clin Gastroenterol Hepatol; 2006 May; 4(5):645-52. PubMed ID: 16630770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
    Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
    Okanoue T; Makiyama A; Nakayama M; Sumida Y; Mitsuyoshi H; Nakajima T; Yasui K; Minami M; Itoh Y
    J Hepatol; 2005 Oct; 43(4):599-605. PubMed ID: 16024129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
    Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
    J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral treatment of HCV carriers with persistently normal ALT levels.
    Puoti C; Bellis L; Galossi A; Guarisco R; Nicodemo S; Spilabotti L; Unto OD
    Mini Rev Med Chem; 2008 Feb; 8(2):150-2. PubMed ID: 18289098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma.
    Puoti C; Guarisco R; Spilabotti L; Bellis L; Mitidieri Costanza O; Dell' Unto O; Elmo MG
    J Viral Hepat; 2012 Apr; 19(4):229-35. PubMed ID: 22404720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States.
    Jamal MM; Soni A; Quinn PG; Wheeler DE; Arora S; Johnston DE
    Hepatology; 1999 Nov; 30(5):1307-11. PubMed ID: 10534355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.
    Puoti C; Bellis L; Guarisco R; Dell' Unto O; Spilabotti L; Costanza OM
    Eur J Intern Med; 2010 Apr; 21(2):57-61. PubMed ID: 20206870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of initially mild chronic hepatitis C.
    Alberti A; Benvegnù L; Boccato S; Ferrari A; Sebastiani G
    Dig Liver Dis; 2004 Oct; 36(10):646-54. PubMed ID: 15506661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.
    Gamberini MR; Francesconi R; Fortini M; Cavazzini L; Lari F; Scapoli C; Ballardini G; De Sanctis V; Bianchi FB
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():259-66. PubMed ID: 16462707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels.
    Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Hennessy T; Williams J; Livingston S; Gretch D
    Liver Int; 2006 Aug; 26(6):643-9. PubMed ID: 16842319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.
    Kyrlagkitsis I; Portmann B; Smith H; O'Grady J; Cramp ME
    Am J Gastroenterol; 2003 Jul; 98(7):1588-93. PubMed ID: 12873583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural history of HCV seropositive cases found in health screening].
    Fukui M
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):69-82. PubMed ID: 7538093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
    Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
    Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.